IN2014CN00834A - - Google Patents
Info
- Publication number
- IN2014CN00834A IN2014CN00834A IN834CHN2014A IN2014CN00834A IN 2014CN00834 A IN2014CN00834 A IN 2014CN00834A IN 834CHN2014 A IN834CHN2014 A IN 834CHN2014A IN 2014CN00834 A IN2014CN00834 A IN 2014CN00834A
- Authority
- IN
- India
- Prior art keywords
- preparation
- isoquinolin
- yloxy
- piperidin
- medicaments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
Abstract
The present invention relates to new crystalline polymorphs of 6 (Piperidin 4 yloxy) 2H isoquinolin 1 one hydrochloride processes for their preparation and their use in particular for the preparation of medicaments.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11305891 | 2011-07-08 | ||
EP11306034 | 2011-12-29 | ||
PCT/EP2012/062444 WO2013007519A1 (en) | 2011-07-08 | 2012-06-27 | Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CN00834A true IN2014CN00834A (en) | 2015-04-03 |
Family
ID=46397259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN834CHN2014 IN2014CN00834A (en) | 2011-07-08 | 2012-06-27 |
Country Status (18)
Country | Link |
---|---|
US (1) | US8598201B2 (en) |
EP (1) | EP2729461B1 (en) |
JP (1) | JP2014518236A (en) |
KR (1) | KR102013567B1 (en) |
CN (1) | CN103781777A (en) |
AU (1) | AU2012283277B2 (en) |
CA (1) | CA2843777C (en) |
CY (1) | CY1117545T1 (en) |
DK (1) | DK2729461T3 (en) |
ES (1) | ES2567317T3 (en) |
HK (1) | HK1192234A1 (en) |
HR (1) | HRP20160358T1 (en) |
HU (1) | HUE028550T2 (en) |
IN (1) | IN2014CN00834A (en) |
PL (1) | PL2729461T3 (en) |
RU (1) | RU2014104357A (en) |
SI (1) | SI2729461T1 (en) |
WO (1) | WO2013007519A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109810173B (en) * | 2017-11-21 | 2020-11-27 | 首都医科大学 | dihydroisoquinoline-3-formyl-TARGD (aa) aa, preparation thereof, and anti-thrombus activity and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2396079A1 (en) * | 2000-01-07 | 2001-07-19 | Transform Pharmaceuticals, Inc. | High-throughput formation, identification, and analysis of diverse solid-forms |
EP1910333B1 (en) * | 2005-07-26 | 2013-05-22 | Sanofi | Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
TW200738682A (en) | 2005-12-08 | 2007-10-16 | Organon Nv | Isoquinoline derivatives |
CA2673916C (en) * | 2006-12-27 | 2015-02-17 | Sanofi-Aventis | Substituted isoquinolone and isoquinolinone derivatives as inhibitors of rho-kinase |
EP2240441B1 (en) | 2007-12-26 | 2015-06-03 | Sanofi | Process for the preparation of 6-substituted-1-(2h)-isoquinolinones |
-
2012
- 2012-06-27 CA CA2843777A patent/CA2843777C/en active Active
- 2012-06-27 RU RU2014104357/04A patent/RU2014104357A/en not_active Application Discontinuation
- 2012-06-27 SI SI201230513A patent/SI2729461T1/en unknown
- 2012-06-27 US US13/534,910 patent/US8598201B2/en active Active
- 2012-06-27 CN CN201280043622.1A patent/CN103781777A/en active Pending
- 2012-06-27 ES ES12730525.8T patent/ES2567317T3/en active Active
- 2012-06-27 IN IN834CHN2014 patent/IN2014CN00834A/en unknown
- 2012-06-27 KR KR1020147003355A patent/KR102013567B1/en active IP Right Grant
- 2012-06-27 HU HUE12730525A patent/HUE028550T2/en unknown
- 2012-06-27 DK DK12730525.8T patent/DK2729461T3/en active
- 2012-06-27 JP JP2014517676A patent/JP2014518236A/en active Pending
- 2012-06-27 PL PL12730525T patent/PL2729461T3/en unknown
- 2012-06-27 AU AU2012283277A patent/AU2012283277B2/en active Active
- 2012-06-27 WO PCT/EP2012/062444 patent/WO2013007519A1/en active Application Filing
- 2012-06-27 EP EP12730525.8A patent/EP2729461B1/en active Active
-
2014
- 2014-06-12 HK HK14105558.7A patent/HK1192234A1/en unknown
-
2016
- 2016-04-07 HR HRP20160358TT patent/HRP20160358T1/en unknown
- 2016-04-19 CY CY20161100324T patent/CY1117545T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2012283277A1 (en) | 2014-02-27 |
EP2729461A1 (en) | 2014-05-14 |
CN103781777A (en) | 2014-05-07 |
HUE028550T2 (en) | 2016-12-28 |
CA2843777A1 (en) | 2013-01-17 |
HRP20160358T1 (en) | 2016-05-06 |
KR20140046460A (en) | 2014-04-18 |
CA2843777C (en) | 2018-11-06 |
CY1117545T1 (en) | 2017-04-26 |
US20130012479A1 (en) | 2013-01-10 |
PL2729461T3 (en) | 2016-06-30 |
WO2013007519A1 (en) | 2013-01-17 |
JP2014518236A (en) | 2014-07-28 |
KR102013567B1 (en) | 2019-08-23 |
SI2729461T1 (en) | 2016-06-30 |
AU2012283277B2 (en) | 2016-07-21 |
HK1192234A1 (en) | 2014-08-15 |
EP2729461B1 (en) | 2016-01-20 |
DK2729461T3 (en) | 2016-04-11 |
RU2014104357A (en) | 2015-08-20 |
US8598201B2 (en) | 2013-12-03 |
ES2567317T3 (en) | 2016-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014MN02598A (en) | ||
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
IN2015DN01119A (en) | ||
MY168300A (en) | Pharmaceutical Composition for Inhalation | |
PH12014501195A1 (en) | Novel 2h-indazoles as ep2, receptor antagonists | |
HK1206938A1 (en) | Process for the preparation of 3-chloro-4,5,6-trifluoro- picolinonitrile 3--456-- | |
MX2014010433A (en) | Novel crystalline form of sitagliptin sulfate. | |
MX2013013465A (en) | Polymorph of rifaximin and process for the preparation thereof. | |
IN2012DN01292A (en) | ||
IN2015DN02616A (en) | ||
GB201107985D0 (en) | Process | |
MX347541B (en) | Sialic acid analogs. | |
AP2012006280A0 (en) | Synthesis process, and crystalline form of 4-ä3-ÄCis-hexahydrocyclopentaÄCÜpyrrol-2(1H)-YLÜpropoxyübenzamide hydrochloride and pharmaceutical compositions containing it. | |
IN2012DE00289A (en) | ||
MY163185A (en) | 2-methoxy-pyridin-4-yl derivatives | |
HK1185615A1 (en) | Process for preparing pan-cdk inhibitors of the formula (i), and intermediates in the preparation (i) pan-cdk | |
IN2014CN00834A (en) | ||
MX2014009084A (en) | Pyrimidooxazocine derivatives as mtor - inhibitors. | |
UA104102C2 (en) | α-CRYSTALLINE FORM OF CARBABENZPYRIDE | |
IN2014CN00817A (en) | ||
MX351994B (en) | Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5 -carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino) -ethyl]-amide. | |
PH12014501760B1 (en) | Method for stereoselective synthesis of 1,4-protected 9-hydroxy-5-oxo-1,4-diaza-spiro[5.5]undecanes | |
MX2013005624A (en) | Novel indolizine derivatives, and preparation and therapeutic use thereof. | |
JO3086B1 (en) | New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid | |
TN2013000128A1 (en) | Process for preparing pan-cdk inhibitors of the formula (1), and intermediates in the preparation |